With a changing model for drug discovery in the industry, in-licensing of early hit compounds is the new way forward for the pharmaceutical industry. In this new paradigm, the roles of biotech companies, research institutes, and academics have changed. ChemRoutes Corporation's novel CROPTM program, developed around its unique spirocycle and bicycle ChemCoresTM and focused ChemArrayTM libraries, has adapted and helped numerous partners cross the valley of death in a cost-effective manner. This presentation will focus on the creation and survival of a nimble private organization and its ability to address the changing model and yet be competitive in how to address the market needs.

Collaborative Research Opportunities Platform (CROP<sup>TM</sup>) program: Fast tracking drug discovery

248th National Meeting (2014)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.

Collaborative Research Opportunities Platform (CROPTM) program: Fast tracking drug discovery

Collaborative Research Opportunities Platform (CROP^TM) program: Fast tracking drug discovery